buck_reed said:I do give credit for your attempts to place some form of quality control on the process. I personally think this is the wrong drug to try it on, though.
The costs of a substance are relaint upon a whole range of factors. You argue that the high cost of illicit substances is related to the inherant dangers of operating illicitly. This is true. However, common pharmaceuticals also have a range of different, yet equally high overheads - just compare the cost of your homebrand paracetamol to panadol. I think that to argue one form would be cheaper than the other is just economic speculation.
buck_reed said:I hate to say it, but given current trends in medical liability, no doctor is going to write you a script for a substance which inadvertantly kills you if you triple the dose. And even if the did go down this road, we have 10-12 years of clinical trials before they release it.
NOW, add the cost of research, packaging, insurance - increase the price by a factor of 10. Would you buy GHB at $30 a dose when you can pick it up illicitly at $5.
Back to square one - try again.
Cheers,
Buck